Related Experiment Video

Updated: May 27, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

[Aetiology and diagnosis of community acquired pneumonia and its complicated forms]

A Andrés Martín1, D Moreno-Pérez, S Alfayate Miguélez

  • 1Anselmo.andres@gmail.com

Anales De Pediatria (Barcelona, Spain : 2003)
|November 29, 2011
PubMed

Insights

Community Acquired Pneumonia (CAP) is a frequent childhood illness. This consensus document provides evidence-based guidance for pediatricians on diagnosing CAP, evaluating diagnostic tests, and understanding their real value.

Area of Science:

  • Pediatric Pulmonology
  • Pediatric Infectious Diseases

Background:

  • Community Acquired Pneumonia (CAP) is a significant pediatric illness requiring multidisciplinary care.
  • Existing diagnostic approaches for CAP necessitate updated, evidence-based guidelines.

Framework:

  • A consensus document developed by the Spanish Society of Paediatric Pulmonology (SENP) and the Spanish Society of Paediatric Infectious Diseases (SEIP).
  • Focuses on practical aspects of CAP diagnosis using evidence-based medicine.

Implementation:

  • Evaluates the etiology and epidemiology of CAP, including current trends.
  • Assesses the utility and validity of various diagnostic tools.
  • Examines laboratory tests like acute phase reactants, microbiological techniques, and imaging.

Implications:

  • Aims to guide pediatricians on the practical value of diagnostic tests for CAP.
  • Enhances diagnostic accuracy and treatment strategies for pediatric CAP.
  • Promotes standardized, evidence-based care for children with pneumonia.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: